Pancreatic Cancer
-
Cancer
Breakthrough News
ICare keeps you up to date on breaking news in
Pancreatic Cancer Research.
Click here to review.
-
24/7 Access to ICARE
We are here for you and committed to helping you
network with the people that can help you.
-
ICARE Registry
The first step in letting us help you, is to let us
get to know about you and your diagnosis better. To do
this we ask that you register with ICARE, if you have not done so
already. This will allow us to keep you updated with
information that may be crucial for your survival.
- Pancreatic
Cancer Therapy Review (CTR)
With registration, you will
receive a Pancreatic Cancer Therapy Review booklet that we publish that provides all the
ICare Pancreatic Cancer therapy information we've
compiled in to one single source. The CTR
booklet includes a description of the disease, staging
procedures, explanations of current treatments and
diagnostic tests, a list of the ongoing clinical
trials, second opinion centers and more. Two versions,
one for the physician and one for the patient, are
available.
Click here to register and
order your Pancreatic Cancer Therapy Review.
-
Pharmaceutical, Clinical, and Research Updates
ICARE Pharmaceutical, Clinical, and Research Updates
are committed to providing cancer survivors with the
latest information available on treatment options,
pharmaceutical news, as well as clinical and research
updates.
- PDQ Information from cancer.gov patient
- PDQ Information from cancer.gov - Health
Professional
-
PEP Centers
Patient Education Partner (PEP)
Centers are a premier example of our patient-centric
information delivery system. It is designed to provide
patients access to an electronic library of cancer
information and on-line hook-ups at the community
level.
-
Patient Experiences
A New On-line (Virtual) Dialog
Approach for Sharing Pancreatic Cancer Therapy Experiences
among patients
-
ICARE Think Tanks
ICARE Think Tanks are small, confidential focus groups
which address therapy issues from a patient's
perspective.
Our process begins when 5 patients establish an agenda
relating to a specific form of cancer. ICARE then
convenes 5 of the top physicians and researchers in
the world, along with the patients, to address that
agenda for a 1-2 day face-to-face meeting.
-
Editorial, Steering and Research Panels
An Editorial, Steering and Research Panels are formed
(or are being formed) for each major type of cancer.
ICARE is forming a tripartite network of patients,
physicians and researchers to provide the driving
force for our programs.
Through these committees, patients are encouraged to
have major input into the content, style and
accomplishments of the ICARE information and research
programs.
-
Private Electronic Support Groups
ICARE's Private Electronic Support Groups are designed
to facilitate private discussions between and/or among
individuals dealing with common types of cancer or
common issues. These support groups will be
established on as "as needed" basis. If you desire
such support, please contact ICARE.
-
Video-Teleconferencing for Second Opinions
Our Video-Teleconferencing for Second Opinions area is
designed to utilize available technology to assist
patients, families, and medical providers in assuring
timely quality access regardless of time and distance
considerations. These support activities will be
established on as "as needed" basis. If you desire
such support, please contact ICARE
ICARE has also compiled a listing of some major cancer
research and treatment centers that offer
"second-opinion" services.
To view these centers click here.
-
Clinical Trial Matching Program
The ICARE Clinical Trial Matching Program builds and
enhances the bridges that provide patients, advocates,
and primary care physicians with access to the latest
relevant on- going global clinical trials sponsored by
government and industry. It provides industry and
academia with an established mechanism to identify and
access patients having the characteristics needed for
a trial. Access is provided to current and up-to-date
information through ICARE.
|
| |
